Puma Biotechnology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PBYI and other ETFs, options, and stocks.

About PBYI

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. 

CEO
Alan H. Auerbach
CEOAlan H. Auerbach
Employees
179
Employees179
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
2010
Founded2010
Employees
179
Employees179

PBYI Key Statistics

Market cap
360.62M
Market cap360.62M
Price-Earnings ratio
14.96
Price-Earnings ratio14.96
Dividend yield
Dividend yield
Average volume
352.58K
Average volume352.58K
High today
$7.33
High today$7.33
Low today
$7.07
Low today$7.07
Open price
$7.20
Open price$7.20
Volume
40.22K
Volume40.22K
52 Week high
$7.90
52 Week high$7.90
52 Week low
$2.85
52 Week low$2.85

Stock Snapshot

As of today, Puma Biotechnology(PBYI) shares are valued at $7.09. The company's market cap stands at 360.62M, with a P/E ratio of 14.96.

As of 2026-05-12, Puma Biotechnology(PBYI) stock has fluctuated between $7.07 and $7.33. The current price stands at $7.09, placing the stock +0.2% above today's low and -3.3% off the high.

Puma Biotechnology(PBYI) shares are trading with a volume of 40.22K, against a daily average of 352.58K.

During the past year, Puma Biotechnology(PBYI) stock moved between $2.85 at its lowest and $7.90 at its peak.

During the past year, Puma Biotechnology(PBYI) stock moved between $2.85 at its lowest and $7.90 at its peak.

PBYI News

TipRanks 4d
Puma Biotechnology Raises Outlook Despite Q1 Reset

Puma Biotechnology ((PBYI)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and...

The Motley Fool 4d
Puma Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. Thursday, May 7, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer, President and Chairman — Alan Auerbach Chief Fi...

Puma Q1 2026 Earnings Call Transcript
TipRanks 5d
Puma Biotechnology reports Q1 adjusted EPS (4c) vs (10c) last year

Reports Q1 revenue $44.8M vs $42M last year. “We are very pleased that the first quarter of 2026 marked another quarter of year-over-year demand increase result...

People also own

Based on the portfolios of people who own PBYI. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.